Abstract
Glioblastoma (GBM) is the most common type of adults brain tumor. Treatment consists of continuous radiotherapy and chemotherapy, with a median survival of 15 to 20 months. Whereas unfavorable prognosis and the limited therapeutic options, the development of new therapies becomes necessary. The inflammatory modulation has a central function in the evolution of GBM, and cytokines may play …